✦ LIBER ✦

Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors

✍ Scribed by M. Gary Brook; Peter Karayiannis; Howard C. Thomas

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 385 KB
Volume: 10
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840100502

No coin nor oath required. For personal study only.

✦ Synopsis

Twenty-one pretreatment variables were assessed for their significance in response prediction using data from 114 patients given a-interferon for chronic hepatitis B virus infection. In those patients who had received a minimum of 90 million units per m2 total dose over 12 weeks, a negative anti-human immunodeficiency virus

📜 SIMILAR VOLUMES

Predictive model of response to therapy

Predictive model of response to therapy with interferon in patients with chronic hepatitis B virus infection: A methodological note

✍ Gioacchino Leandro; M. G. Brook; P. Karayiannis; H. C. Thomas 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Efficacy of low-dose intermittent interf

Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy

✍ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract The efficacy of interferon (IFN) monotherapy for non‐responders to pegylated interferon (PEG‐IFN) plus ribavirin (RBV) combination therapy is still unclear. To evaluate the impact of IFN monotherapy on biochemical response, 200 consecutive patients infected with HCV genotype 1b, who rec

Predictive factors of virological non-re

Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the

Allogeneic bone marrow transplantation f

Allogeneic bone marrow transplantation for a patient complicated by chronic hepatitis due to precore mutant hepatitis B virus: Failure of management with interferon-α therapy

✍ Miura, Yuji; Takamatsu, Hideyuki; Okumura, Hirokazu; Yoshida, Takashi; Nakao, Sh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon